synced 2 MIN AGO
01 Record

CVE-2020-14490

OpenClinic GA

HighPUBLISHEDCNA: icscert
CNA base score8.8 CVSS v3.xCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

02 Description

OpenClinic GA

03 Exploitation and scoring

Exploitation
Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.
SSVC decision
Not assessed by CISA
EPSS probability
2.45% probability of exploitation activity in the next 30 days.
EPSS percentile
Equal to or higher than the score of 84.0% of scored records. A rank, not a probability.
NVD base score
8.8 (CVSS v3.x), scored by the NVD independently of the CNA.
NVD CVSS vector
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
NVD analysis status
Modified. NVD last modified this record on 2026-06-17.
Red Hat severity
No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

04 Metadata

Published
2020-07-29 12:25Z6 YR AGO
Last updated
2024-09-16 17:03Z2 YR AGO
Reserved
2020-06-19
Assigning CNA
icscert
Record state
PUBLISHED
Severity
High (CVSS 8.8)
CNA CVSS vector
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weaknesses
  • CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')Base
Data version
5.1
Document digest
26f6be60d2c8ba64e6577f0bb2268f06b5b960c0bead54d35f1ec8ade1739f76

05 Affected products

VendorProductVersionsPlatforms
open sourceOpenClinic GA5.09.02, 5.89.05b—

06 References